Genomics

Genomic innovation is accelerating the transition to faster diagnostics, scalable biomanufacturing, and precision therapies. The analyst’s latest FutureTech Series: Genomics report delivers a comprehensive analysis of the technologies redefining molecular healthcare. The report highlights automated DNA extraction, metagenomic pathogen detection, genome-edited iPSC therapies, plasmid DNA extraction kits, and isothermal DNA amplification, each positioned to address critical challenges in clinical reliability, decentralized testing, and therapeutic accessibility. Using the analyst’s proprietary Tech Foresights platform, the report examines innovation drivers, challenges, patent leadership, and real-world applications, providing essential strategic guidance for R&D leaders and decision-makers.

Report Scope

• Sector innovation radar chart identifies key disruptive forces within the genomics theme
• High-impact innovations are ranked in the genomics theme by their projected impact and include their supplementary patent details
• Innovations deep-dive gives an overview and highlights patent indicators, key enterprise and startup/university innovators, and market buzz of select innovations
• Methodology details on how the innovations and companies are listed into select categories

Reasons to Buy

• The analyst’s FutureTech Series Reports are aimed at capturing futuristic technologies which have the potential to disrupt tomorrow.
• These technologies are constantly changing, adapting, and progressing to enable a paradigm shift in our daily lives.
• The awareness, knowledge, and expertise of these topics help transform business models and strategic thinking with an in-depth understanding of megatrends that can directly influence patenting, collaboration, acquisition, and investment decisions.